Browse through our press and news section by category:

12.05.2011, SCHOTT AG, Düsseldorf (Germany)

SCHOTT Pharmaceutical Systems expands its Worldwide Network

New Production Plant in Russia
May 12, 2011 (interpack Duesseldorf, Germany) – SCHOTT Pharmaceutical Systems, one of the world’s leading suppliers of glass tubing and primary packaging for the pharmaceutical industry, continues to expand its global network. The company will open up a new production plant in Russia this month and plans to further strengthen its position in Japan.

At the end of May 2011, the company will officially inaugurate a new manufacturing facility in Russia. Located in Zavolzhe, near the Russian city of Nizhny Novgorod, the new production site will employ around 60 employees initially and will produce premium quality ampoules and vials. All products will be manufactured according to cGMP guidelines (current Good Manufacturing Practices) and meet the high international standards for primary pharmaceutical packaging.

SCHOTT is the first international group, which manufactures primary pharmaceutical packaging made of glass, to open a production facility in Russia. With its packaging expertise and quality commitment, SCHOTT will support Russian pharmaceutical companies in meeting the requirements of “Pharma 2020”. The company has been selling ampoules, vials, cartridges and syringes to the Russian market already since the beginning of the 1990s. So far, Russian customers have been mainly supplied from the existing pharmaceutical packaging site in Hungary.

Furthermore, SCHOTT has formed a joint venture with Japanese company Naigai Glass Industry Co., Ltd. at the end of 2010 in order to strengthen its position in Japan, the world’s second largest pharmaceutical market. The new company, SCHOTT NAIGAI K.K., is based in Osaka, Japan, where Naigai has already been operating a production site for many years. Under the terms of the joint venture, Naigai shifted its existing vial manufacturing activities over to the new company and SCHOTT contributed its highly advanced Automated Inspection System (AIS), which is even more reliable than human eye inspection.

With new business operations in major growth markets such as China and Argentina, SCHOTT has already expanded its global network of pharmaceutical packaging production plants in recent years. With more than 600 production lines in 14 countries around the world, SCHOTT manufactures over seven billion syringes, vials, ampoules, cartridges, and special products for the pharmaceutical industry each year.

“Our global production network allows us to be close to our customers who benefit from the high quality and technology standards,” says Dr. Jürgen Sackhoff, Executive Vice President of SCHOTT Pharmaceutical Systems. “These global production capacities also allow for supply safety along the entire supply chain.”

Number of characters: 2,776 (including empty spaces)

About SCHOTT Pharmaceutical Systems
SCHOTT Pharmaceutical Systems is one of the world’s leading suppliers of glass tubing and primary packaging for the pharmaceutical industry. We provide our customers quality solutions while meeting their highest demands with our material expertise, specialized analytical lab services, and a broad product portfolio; including, syringes, cartridges, vials, ampoules, and special articles made of glass and COC polymer. With four glass tubing production sites and fifteen sites for pharmaceutical packaging spread over four continents, we offer safe supply and local service. Our state-of-the-art production facilities and our products comply with the highest international quality standards for pharmaceutical needs.

SCHOTT is an international technology group that has been developing and producing speciality materials, components, and systems for over 125 years. The company’s core markets are the household appliance industry, solar power, pharmaceuticals, electronics, optics, the automotive industry and architecture. SCHOTT Group maintains close proximity to its customers with manufacturing and sales companies in all major markets. Its workforce of around 17,500 employees generated worldwide sales of approximately 2.9 billion euros for the 2009/2010 fiscal year. The company's technological and economic expertise is closely linked with its social and ecological responsibility. At the same time, SCHOTT strongly supports the principles of sustainability. SCHOTT AG is owned by the Carl Zeiss Foundation.
Press contact
SCHOTT forma vitrum ag
Christa Fritschi
St. Gallen
Phone: +41 (0) 71 274-1602
Further information
Klaus Bernhard Hofmann
Leiter Corporate Public Relations
Hattenbergstraße 10
55122 Mainz
Phone: +49 6131/66-3662
Fax: +49 3641/2888-9140
SCHOTT uses Cookies on this Website to enhance the user experience and provide the best possible Service. By continuing to browse the Website, you consent to our use of Cookies.